Blood Transfusion Flashcards

1
Q

Blood group

A
  • Red blood cells are covered by proteins that make up a personโ€™s blood group. The four major blood groups are O, A, B, and AB.
  • About 85 percent of the people in the United States have a substance on their red blood cells called the โ€œRh factor.โ€ These people are โ€œRh positive.โ€ The remaining 15 percent of Americans are called โ€œโ€Rh negativeโ€ because they do not have the Rh factor.
    โ€” This is why a personโ€™s blood may be referred to as โ€œA positiveโ€ (group A, Rh positive) or โ€œO negativeโ€ (group O, Rh negative).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Whole blood:

A
  • Blood with all blood components intact
  • contains all blood components: RBCs, WBCs, Platelets, Plasma, Clotting factors, Immunoglobulins
  • transfused 24 hours after collection due to degradation of clotting factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Whole blood Indication:

A
  • (rarely used) to rapidly restore blood volume and oxygen-carrying capability of blood, as in cases of blood loss from hemorrhage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Whole blood Administration:

A

Give whole blood or packed RBCs through a Y-type I.V. set with a 170-micron filter unless a 20- to 40- micron filter (for microaggregates from degenerating platelets and fibrin strands) is ordered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Red blood cells (RBCs):

A
  • Whole blood with 80% of plasma removed & platelets removed; volume usually 250 mL
  • contain hemoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Red blood cells (RBCs) Indication:

A
  • to maintain or boost oxygen-carrying capability of the blood, as in cases of:
    โ€” blood loss from GI bleeding or surgery
    โ€” RBC destruction from chemotherapy
  • contain hemoglobin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Red blood cells (RBCs) Administration:

A

Give whole blood or packed RBCs through a Y-type I.V. set with a 170-micron filter unless a 20- to 40- micron filter (for microaggregates from degenerating platelets and fibrin strands) is ordered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Leukocyte-poor RBCs:

A

Same as RBCs but with about 95% of leukocytes removed; volume about 200 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Leukocyte-poor RBCs Indication:

A

for treatment of febrile nonhemolytic transfusion reaction caused by WBC antigens reacting with a patientโ€™s WBC antibodies or platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

leukocyte-poor RBCs Administration:

A

Administer leukocyte-poor RBCs with a straight-line or Y-type I.V. set to infuse blood over 1 1/2 to 4 hours. Use a 40-micron filter suitable for hard-spun leukocyte-poor RBCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hemoglobin

A

Each unit of whole blood or RBCs contains enough hemoglobin (Hb) to raise the Hb level in an average- size adult by 1 g/dL (about 3%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

White blood cells (WBCs, also called leukocytes):

A

Whole blood with all RBCs and about 80% of plasma removed; volume usually 150 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

White blood cells (WBCs, also called leukocytes) Indication:

A
  • to treat sepsis that is unresponsive to antibiotics (especially if the patient has blood cultures positive for sepsis or a persistent fever that exceeds 101ยฐ F [38.3ยฐ C] and granulocytopenia [granulocyte count usually less than 500/ฮผL])
  • When administering WBCs, premedicate with diphenhydramine (Benadryl), as prescribed.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

WBC Administration:

A

Administer WBCs using a straight-line I.V. set with a standard in-line blood filter to provide 1 unit daily for 5 days or until the infection resolves.
- Because a WBC infusion induces fever and chills, administer an antipyretic if fever occurs. Donโ€™t discontinue the transfusion; instead, reduce the flow rate, as ordered, for patient comfort.
- Agitate the WBC container to prevent settling, thus preventing the delivery of a bolus infusion of WBCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Platelets

A

Fragments of large bone marrow cells (called megakaryocytes) that help with clotting; volume 35 to 50 mL/unit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Platelets Indication:

A

to treat thrombocytopenia caused by decreased platelet production, increased platelet destruction, or massive transfusion of stored blood; to treat acute leukemia and marrow aplasia; and to improve platelet count preoperatively in a patient whose count is 100,000/ฮผL or less

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Platelet Administration:

A
  • Platelets require a component drip administration set to infuse 100 mL over 15 minutes. As prescribed, premedicate with an antipyretic and an antihistamine if the patientโ€™s history includes a platelet transfusion reaction. If the patient has a fever before administration, notify the practitioner for probable delay of the transfusion.
  • Prepare to draw blood for a platelet count, as ordered, 1 hour after platelet administration to determine platelet transfusion increments.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Fresh frozen plasma (FFP):

A

Uncoagulated plasma separated from RBCs and rich in coagulation factors V, VIII, and IX; 5,8,9
volume 200 to 250 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Fresh frozen plasma (FFP) Indication:

A
  • to correct an undetermined coagulation factor deficiency
  • to replace a specific factor when it isnโ€™t available
  • to correct factor deficiencies resulting from hepatic disease
  • WARNING!: FFP is no longer indicated for use as a volume expander because of its high load of clotting factors. Itโ€™s also contraindicated as prophylaxis after cardiopulmonary bypass surgery or with massive blood transfusions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Fresh frozen plasma (FFP) Administration:

A
  • For FFP, use a straight-line I.V. set, and administer the infusion rapidly.
  • Keep in mind that large-volume transfusions of FFP may require correction for hypocalcemia because citric acid in FFP binds calcium.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Cryo: Cryopercipitate:

A

often referred to as Cryo is the precipitated material obtained from FFP when thawed. It contains coagulation factors VIII and XIII;
8 & 13,
Bogen, von Willebrand factor, and fibronectin. It is given to prevent or control, bleeding in patients with hemophilia, von Willebrand disease, to correct low fibrinogen levels, and for other clotting disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Albumin 5% (buffered saline) and albumin 25% (salt-poor saline):

A

Small plasma protein prepared by fractionating pooled plasma; volume of 5%, 12.5 g/250 mL; volume of 25%, 12.5 g/50 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Albumin Indication:

A
  • to replace volume lost because of shock from burns, trauma, surgery, or infections; to replace volume and prevent marked hemoconcentration; and to treat hypoproteinemia (with or without edema)
  • WARNING! : Keep in mind that albumin is contraindicated in patients with severe anemia and must be administered cautiously to those with cardiac or pulmonary disease because of the risk of heart failure from circulatory overload.
24
Q

Albumin Administration:

A

For albumin, use a straight-line I.V. set with rate and volume dictated by the patientโ€™s condition and response.

25
Q

Factor VIII:

A

Insoluble portion of plasma recovered from FFP; volume about 30 mL (freeze-dried)

26
Q

Factor VIII Indication:

A

Factor VIII to treat hemophilia A, to control bleeding associated with factor VIII deficiency, and to replace fibrinogen or deficient factor VIII

27
Q

Factor VIII Administration:

A

For factor VIII, use the administration set supplied by the manufacturer. Administer with a filter; the standard dose recommended for the treatment of acute bleeding episodes in patients with hemophilia is 15 to 20 units/kg.

28
Q

Factors II, VII, IX, and X complex (prothrombin complex): 2,7,9,10

A

Lyophilized, commercially prepared solution drawn from pooled plasma

29
Q

Factors II, VII, IX, and X complex Indications:

A
  • to treat a congenital factor V deficiency and other bleeding disorders resulting from an acquired deficiency of factors II, VII, IX, and X
  • WARNING!: Factors II, VII, IX, and X complex transfusions are contraindicated in patients with hepatic disease resulting in fibrinolysis and in patients with disseminated intravascular coagulation who arenโ€™t undergoing heparin therapy.
  • Draw blood for a coagulation assay before administering factors II, VII, IX, and X complex and at suitable intervals during treatment.
30
Q

factors II, VII, IX, and X complex Administration:

A
  • Administer factors II, VII, IX, and X complex with a straight-line I.V. set, basing the dose on the desired factor level and the patientโ€™s weight, as ordered.
  • Note that the half-life of factor VII is 8 to 10 hours, which necessitates repeated transfusions at specified intervals to maintain normal levels.
31
Q

Alternatives to blood transfusions

A

when specific blood components are adequate but volume has been lost, alternatives are:
- normal saline
- lactated Ringer solution
- albumin
- purified protein fractions
- hydroxyethyl starch
- dextrans

32
Q

Cross-matching

A

Before your transfusion, your blood will be drawn for cross-matching. During cross-matching, a sample of your blood is mixed with a sample from a blood donor. If the blood cells do not clump together, your blood is compatible, and the transfusion can be given.

33
Q

Typenex bracelet

A
  • When your blood is drawn for cross-matching, a special red Typenex bracelet will be placed on your wrist. This bracelet will be checked by your nurse before your transfusion begins.
  • Please do not remove the bracelet until after your transfusion.
34
Q

Informed consent

A
  • Before you get your transfusion, you will be asked to read and sign an Informed Consent for Transfusion of Blood or Blood Components. (If an emergency arises and you have not had the chance to sign this form, you will still get the blood you need.) This form explains why the transfusion is needed, as well as risks, benefits, and choices about where the blood or blood components come from.
  • For example, some patients prefer to be given their own blood (autologous donation).
    โ€” Autologous blood is donated by a patient who qualifies to donate before a planned procedure. You can donate blood weeks before your surgery, either at NIH or at your local hospital. If you choose not to donate blood at NIH, your blood will be shipped in time for your surgery. Others wish to be given a transfusion from someone of their choosing (directed donation). Many patients choose directed donation, but there is no evidence that it is safer than getting blood from a volunteer community donor.
35
Q

Pretreatment Care

A
  • Explain to the patient and family or caregiver the reason for the transfusion and the steps in the procedure.
  • Unless the transfusion is an emergency, verify that the patient has signed an appropriate informed consent form.
  • Make sure the patientโ€™s religious beliefs donโ€™t prohibit blood transfusion therapy.
  • Record the patientโ€™s baseline vital signs.
  • Follow your facilityโ€™s policy for continued monitoring of vital signs during the transfusion.
  • Obtain the blood product from the blood bank no more than 30 minutes before starting the transfusion.
  • WARNING!:
    โ€” Never store blood in a non-blood bank refrigerator. Return blood to the blood bank refrigerator if you anticipate a delay of 30 minutes or more.
  • Check the expiration date on the component bag, and inspect for abnormal color, clumping, gas bubbles, and extraneous material.
  • Return outdated or abnormal components to the blood bank.
36
Q

2 nurse Prep Check:

A
  • According to The Joint Commissionโ€™s standards and most facilitiesโ€™ policies, two nurses or practitioners are required to Use a two-person verification process to match the blood or blood component to the practitionerโ€™s order and to match the patient to the blood component before transfusion to prevent errors and a potentially fatal reaction.
  • Perform identification of blood and blood products at the patientโ€™s bedside with another licensed professional, according to facility policy.
    โ€” One of the people conducting the verification must be the qualified person, usually a registered nurse, who will administer the blood or blood component to the patient.
    โ€” The second person conducting the verification must be qualified to participate in the process, as determined by your facilityโ€™s policy.
  • Compare/check:
    โ€” Pt
    โ€” name
    โ€” medical record number on the identification band
    blood bank identification number
  • Check the component bag label
    โ€” blood bank identification number
    โ€” ABO blood group
    โ€” Rh compatibility
  • WARNING!
    โ€” ABO incompatibility from mistakes in blood product labeling or patient identification is the major cause of fatal hemolytic transfusion reactions.
37
Q

Procedure

A
  • The transfusion will be given either in your room or in the outpatient clinic.
  • If the patient doesnโ€™t have an I.V. line in place, perform a venipuncture using a 20G or larger catheter (18G) or the transfuse through central venous line
  • Prepare a bag of normal saline solution to flush the line before and after transfusion or to keep the vein open during a reaction or between transfusions.
  • Obtain an infusion pump suitable for administering blood, according to your facilityโ€™s policy.
    โ€” Obtain a blood warmer, if ordered, to prevent hypothermia from rapid infusion of large volumes of blood.
  • Only normal saline solution is compatible with blood and plasma products.
  • Vital signs (pulse, respiration, temperature) will be taken before, during, and after the transfusion.
  • If you have had transfusion reactions, you may be given medication (Tylenol and Benadryl) 30 minutes before your transfusion.
  • Unless you are on a special diet, you may eat or drink what you like during the transfusion.
  • You may also get up and move around. Just make sure to keep your movements slow and easy so that the needle and tubing do not come loose.
  • If you feel any discomfort from the needle, please let your nurse know right away.
  • Transfusing one unit of red blood cells takes about 1 1/2 to 2 hours, but other blood components, such as platelets, take less time to give. Often, electronic pumps are used to regulate the speed of a transfusion.
38
Q

Geriatric consideration

A
  • Elderly patients require a smaller-diameter catheter, such as 20G, for RBC transfusion because they have smaller veins.
  • Prepare a bag of normal saline solution to flush the line before and after transfusion or to keep the vein open during a reaction or between transfusions.
  • Obtain an infusion pump suitable for administering blood, according to your facilityโ€™s policy.
  • Obtain a blood warmer, if ordered, to prevent hypothermia from rapid infusion of large volumes of blood.
39
Q

Normal Saline!:

A
  • Only normal saline solution is compatible with blood and plasma products.
  • Never start a transfusion in an I.V. line that has been used for another infusion without completely flushing the line with saline solution.
    โ€” Only normal saline solution is isotonic and calcium-free. Calcium binds with the citrate anticoagulant in the blood bag and promotes clotting in the tubing.
    โ€” Excess glucose causes hemolysis and shortens RBC survival.
  • Also, do not piggyback a blood administration set into a main line that has been used for any solution other than normal saline solution.
40
Q

IV Rate beginning procedure:

A
  • Monitor the patient closely and adjust the flow rate to no greater than 2 mL/minute for the first 15 minutes of the transfusion to observe for a possible transfusion reaction.
  • Remain with the patient and frequently reassess vital signs and blood pressure, facial color, and any complaints for the first 15 minutes.
  • If no signs of a reaction appear within 15 minutes, adjust the flow to the ordered infusion rate, which should be as rapid as the circulatory system can tolerate.
  • Observe the patient at least every 30 minutes during the transfusion to identify early signs and symptoms of a possible transfusion reaction and to monitor the I.V. insertion site for signs of infiltration.
41
Q

IV Rate after procedure:

A
  • After completion, flush the administration set and I.V. catheter with normal saline solution.
  • Remove and discard the infusion equipment and reconnect the original I.V. fluid, if necessary, or discontinue the I.V. access.
  • Discard the blood bag, tubing, and filter in an appropriate hazardous waste container.
  • Monitor and assess the patient for signs and symptoms of a delayed transfusion reaction for 4 to 6 hours after the transfusion. (GVHD)
  • If the patient isnโ€™t under direct observation after the transfusion (for example, if the patient receives a transfusion as an outpatient), provide patient teaching about signs and symptoms of a delayed transfusion reaction and the importance of reporting them.
42
Q

First steps if Transfusion reaction happens:

A
  • If signs of a reaction develop, immediately stop the transfusion and record the patientโ€™s vital signs.
  • Infuse normal saline solution through a new I.V. line at a keep-vein-open rate, and notify the practitioner.
  • Save the blood product bag for return to the blood bank. Do not throw away.
  • Obtain urine and blood samples, and send them to the laboratory.
43
Q

After the procedure

A
  • After the transfusion, you may do your normal activities.
  • Though it is uncommon, delayed transfusion reactions can occur days or weeks after the procedure.
  • Symptoms of a delayed transfusion reaction are fever, muscle aches, and dark urine. If you think you are having a delayed reaction to your transfusion, notify a member of your health care team right away
44
Q

Posttreatment Care

A
  • If necessary, change the blood or blood component administration set, using sterile technique, after infusing each unit or after 4 hours.
  • Change it immediately if you suspect contamination or if the integrity of the product or system becomes compromised.
  • Change the filter whenever you change the tubing, unless otherwise indicated by the manufacturerโ€™s instructions.
  • If a hematoma develops at the I.V. site, immediately stop the transfusion and remove the I.V. cannula.
  • Notify the practitioner and prepare to apply ice to the site intermittently for 8 hours. Then apply warm compresses, according to your facilityโ€™s policy.
  • Monitor the patientโ€™s intake and output as well as lung status, and watch for edema to prevent fluid overload.
  • After completing the transfusion, adhere to standard precautions and remove and discard the used infusion equipment in a biohazard materials receptacle.
  • Reconnect the original I.V. fluid, if necessary, or discontinue the I.V. infusion.
  • Return the empty component bag to the blood bank if facility policy dictates.
  • Record the patientโ€™s vital signs.
45
Q

Reactions to the transfusion

A
  • During, or right after the transfusion, some patients have a โ€œtransfusion reaction.โ€ Symptoms are usually mild and include hives, itching, rashes, fever, chills, muscle aches, back pain, chest pain, headache, and heat where you got the transfusion or along the vein. If you have these symptoms, or feel anything unusual, tell your nurse immediately. If you have had a transfusion reaction in the past, please let your doctor or nurse know before you get a transfusion.
46
Q

Patient Teaching

A

Be sure to include the patientโ€™s family or caregiver in your teaching, when appropriate.

47
Q

General

A
  • Teach the patient to immediately report the following symptoms:
    โ€” flushing, feverish feeling chills, nausea, or headache (transfusion reaction)
    โ€” palpitations (with hypotension, arrhythmia, shaking, or chills may be a sign of hypothermia)
    โ€” difficulty swallowing or breathing (possible anaphylaxis)
    tingling in the fingers, muscle cramps, nausea, vomiting, or faintness (with hypotension, arrhythmias, and seizures, may signal hypocalcemia from citrate toxicity or liver impairment)
    โ€” intestinal colic, diarrhea, or muscle weakness (with irritability, oliguria, T-wave changes on electrocardiogram, and bradycardia, may signal hyperkalemia from large-volume transfusions).
    โ€” graft vs. host disease: happens days - weeks after infusion
    โ€”- rash head to toe
  • Explain to the patient that additional transfusions may be needed.
  • Inform the patient that you may need to collect specimens to evaluate the effectiveness of therapy.
48
Q

Complications

A
  • Transfusion reaction
  • Infectious disease transmission
  • Hepatitis C
  • Circulatory overload
  • Hemolytic reactions
  • Coagulation disturbances
  • Citrate intoxication
  • Hyperkalemia
  • Acid-base imbalance
  • Allergic, febrile, and pyogenic reactions
  • Hypothermia
  • Acute lung injury
49
Q

Nursing Diagnoses

A
  • Activity intolerance
  • Deficient fluid volume
  • Deficient knowledge: Disease process
  • Risk for decreased cardiac tissue perfusion
  • Risk for ineffective cerebral tissue perfusion
  • Risk for ineffective renal perfusion
  • Risk for injury
50
Q

Expected Outcomes

A
  • The patient will:
    โ€” demonstrate an increased ability to perform activities of daily living
    โ€” maintain adequate fluid volume
    โ€” verbalize an understanding of the need for the transfusion and the steps involved
    โ€” maintain adequate cardiac tissue perfusion
    โ€” demonstrate an alert level of consciousness
    โ€” exhibit adequate renal perfusion
    โ€” remain free from complications, including a transfusion reaction.
51
Q

Universal donor

A

type O

52
Q

universal recipient

A

type AB

53
Q

Call MD if baseline temp is

A

> 100 F

54
Q

start transfusion/ vs:

A
  • slow; 2ml/min (120mL/hr) for the first 15 min
  • 5 min into transfusion: take vital signs
  • 15 mins after transfusion: take vital signs; if stable, increase IV rate to finish within 2-4 hours)
  • 30 min into transfusion: take vital signs if stable switch VS frequency to 1 hourly until done
  • 1 hour after transfusion: VS
55
Q

Transfusion reaction:

A
  • rash
  • fever (increase of 1ยฐ C or 1.8ยฐ F)
  • Most common; people who have received blood in the past.
  • body creates antibodies
  • Aches
  • Chills
  • Tachycardia
  • tachypnea
  • UOP Low (hemoglobinuria: purple color
  • NVD
56
Q

Transfusion reaction labs:

A
  • Clotting; DIC
  • Electrolytes
  • Renal blood levels
  • urine: free hemoglobin
57
Q

900mL PRBC to infuse over 4 hours

A
  • 1st 15 min:
    โ€” 2ml/min = 30 ml/ 15 min @ 120ml/hr
  • next 3.75 hours:
    โ€” 870mL remaining = 870mL infused @ 232ml/hr